Oracle-funded study improves treatment prospects for cancer patients
Read the ICR’s latest blog post about the success of our recent Oracle-funded study into combining radiotherapies with viruses to improve treatment prospects for cancer patients.
Oracle-funded scientists at the ICR and The Royal Marsden NHS Foundation Trust combined the oncolytic reovirus RT3D, with radiotherapy to treat melanoma, and found that the combination was much more effective than separate treatments.
Read the full report here:
Tractor N’ Tinsel Run & Market
Tractor N’ Tinsel Run & Market is now in its fourth year with over 150 tractors decorated.
World Radiotherapy Awareness Day 14th November
WRAD2025 has 250+ global organisations united for a crucial cause in radiotherapy best practice
Big #Cancer52 Conversation
Insightful discussions at the Big #Cancer52 Conversation focusing on reducing health inequalities.
National cancer plan
Government committed to a stand-alone cancer strategy and the importance of a national cancer plan.
£70m funding for radiotherapy
The recent announcement of £70 million in government funding for modern radiotherapy is welcome news
Rising rates of head and neck cancers in England
A new report from the University of Sheffield that highlights rising rates of head and neck cancer in England.
Research – Small Grants Programme opportunity
Small Grants Programme, offering a total funding £55,000 to support 1-3 innovative research projects.
Match Funding Appeal
Oracle HNCUK has an extraordinary opportunity to help research through an amazing Match Funding Appeal
Help Beat Head and Neck Cancer
Follow us
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.